2型糖尿病患者给予早期胰岛素强化治疗的综合临床价值探析  

Comprehensive Clinical Value of Type 2 Diabetes Mellitus with Early Intensive Insulin Therapy

作　　者：符兰芳[1] 蒙绪标[1] 熊青[1] 刘婷婷[1] 罗德钦[1] 林慧[1] Fu Lan-fang;Meng Xu-biao;Xiong Qing(Department of Endocrinology,Haikou Municipal People's Hospital,Hainan Province,Haikou 570208, China)

机构地区：[1]海南省海口市人民医院内分泌科,海口570208

出　　处：《中国医药导刊》2016年第8期817-819,共3页Chinese Journal of Medicinal Guide

摘　　要：目的:分析讨论初诊2型糖尿病患者给予早期胰岛素强化治疗的可行性与安全性。方法:对照组35例患者给予口服降糖药物治疗,实验组35例患者则采取早期胰岛素强化治疗,比较两组患者治疗前后胰岛β细胞功能与血糖控制效果等的差异,统计不良反应发生情况。结果:实验组治疗后胰岛β细胞功能各指标与FBG、2hPG、HbA1c等血糖指标比对照组改善幅度显著更大(P<0.05):两组无明显不良反应。结论:对初诊2型糖尿病患者施以早期胰岛素强化治疗有助于改善胰岛β细胞功能与正常血糖水平的长期维持,安全性好。Objective: To analyze the discussion of newly diagnosed type 2 diabetes were treated with intensive insulin therapy early feasibility and safety.Methods:The control group of 35 patients treated with oral hypoglycemic drugs,experimental group of 35 patients are taking early intensive insulin therapy,differences in islet β-cell function and glycemic control effects were compared before and after treatment,statistics adverse reactions.Results:The experimental group after treatment of islet β-cell function indexes and FBG,2hPG,HbAlc blood glucose and other indicators than the control group improved significantly greater amplitude(P<0.05);There was no significant adverse reactions.Conclusion:Newly diagnosed type 2 diabetic patients subjected to intensive insulin therapy helps to improve islet β-cell function and long-term maintenance of normal blood sugar levels,good security.

关 键 词：2型糖尿病 早期胰岛素强化 胰岛Β细胞功能 血糖 

分 类 号：R587.1[医药卫生—内分泌]